Search Results 1291-1300 of 18568 for vitamin toxicity

  1. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Persistent toxicities ≥ grade 2 from prior chemotherapy or biological therapy regardless of interval since last treatment; Active cardiac disease including ...

  2. Dr. Jon Ebbert Archives - Mayo Clinic News Network

    ... toxic exposures," says Dr. Ebbert. These toxic ingredients may contribute to vaping-related illness. "What we're trying to do in our lab is really focus on ...

  3. Methylprednisolone (injection route) - Side effects & uses - Mayo Clinic

    This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements. Back to top. Side Effects. Along with its ...

  4. Publications - Will J. Binder, Jr., M.D., Pharm.D. - Mayo Clinic

    Binder WJ, Stearns JD, Gorlin AW. Parenteral Meperidine: a Review of the Pharmacology and Clinical Applications. Curr Anesthesiol Rep. 2023. Harbell MW, Binder ...

  5. Regorafenib (oral route) - Side effects & dosage - Mayo Clinic

    This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal (eg, St. John's wort) or vitamin supplements. Back to top ...

  6. Gut Permeability, Sensitivity and Symptomatology - Mayo Clinic

    Inclusion Criteria. No abdominal surgery (except appendectomy, cholecystectomy, hernia repair, hysterectomy, and C-section). Written informed consent.

  7. A Study to Evaluate Precision Pharmacogenomics in Cancer Patients - Mayo Clinic

    About this study. THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a ...

  8. A Study Comparing Recombinant Von Willebrand Factor (RVWF) Vs. Tranexamic Acid (TA) To Minimize Menorrhagia In Women With Type 1 Von Willebrand Disease - Mayo Clinic

    A Study Comparing Recombinant Von Willebrand Factor (RVWF) Vs. Tranexamic Acid (TA) To Minimize Menorrhagia In Women With Type 1 Von Willebrand Disease.

  9. Selected Publications by Faculty and Fellows Source: Cho, J. Seville, MT. Khanna, S. Pardi, DS. Sampathkumar, P. Kashyap, PC. Sc

    Source: Cho, J. Seville, MT. Khanna, S. Pardi, DS. Sampathkumar, P. Kashyap, PC. Screening for. Clostridium difficile colonization on admission to a ...

  10. Bispecific antibody therapy - Mayo Clinic

    Bispecific antibody toxicities. CMAJ. 2025; doi:10.1503/cmaj.241384. Morris EC, et al. Cytokine release syndrome and associated neurotoxicity in cancer ...